Abstract: The present invention features a method for determining the methyltransferase activity of a polypeptide and screening for modulators of methyltransferase activity, more particularly for modulators of the methylation of retinoblastoma by SMYD3. The invention further provides a method or pharmaceutical composition for prevention or treating of colorectal cancer, hepatocellular carcinoma, bladder cancer and/or breast cancer using a modulator so identified. N-terminal truncated forms of SMYD3 (alias ZNFN3A1) have higher methylating activity. Lys 824 is a preferred methylation site on the RB1 protein for SMYD3.
Type:
Application
Filed:
June 23, 2006
Publication date:
July 30, 2009
Applicants:
Oncotherapy Science, Inc., The University of Tokyo
Abstract: An electrode device and a method of installing the electrode device in the vicinity of the brain. The electrode device includes a plurality of electrode assemblies, each with at least one electrode lead, extending from a common base. The base is configured to be positioned on an outside of the patient's cranium with each electrode assembly projecting individually through a hole in the patient's cranium such that the electrode lead is in the vicinity of the brain. The method of installation includes carving a recess out of the patient's cranium and inserting the base therein. Each of the electrode assemblies are placed in their respective holes in order to stimulate, monitor or record neurological activity. The electrode device may be used over long periods of time for chronic treatment or recording.
Abstract: Disclosed are a base station and mobile station to adaptively control a bandwidth of a channel. The base station includes a state information recognition unit to recognize neighboring-state information related with a traffic load of at least one neighboring network adjacent to a target network, a control state information transmitting unit to transmit control state information related with the controlled bandwidth of the target channel to mobile stations of the target network, and a bandwidth control unit to control a bandwidth of a target channel used in the target network according to a bandwidth of a channel used in the neighboring network based on the neighboring-state information.
Type:
Application
Filed:
May 7, 2008
Publication date:
July 30, 2009
Applicants:
Samsung Electronics Co., Ltd., Seoul National University Industry Foundation
Inventors:
Kyung Hun JANG, Hyo Sun Hwang, Sunghyun Choi, Hyewon Lee, Kwanghun Han, Youngwoo Hwang
Abstract: A piezoelectric sensor having a plurality of electrodes deposited on a single surface of the dielectric medium is generally provided. The plurality of electrodes can define a plurality of square-shaped electrodes forming a grid on the first surface of the dielectric medium while the second electrode defines a continuous electrode. An electrode border surrounding the plurality of electrodes can be deposited on the first surface of the dielectric medium. Alternatively, the plurality of electrodes can define column-shaped electrodes, while the second electrode defines a plurality of row-shaped electrodes separated by etchings. The direction of orientation of each column-shaped electrode and the direction of orientation of each row-shaped electrode can be substantially perpendicular. A method of making a piezoelectric sensor is also provided.
Abstract: The present invention relates to a method for culturing tenocytes. In particular the present invention relates to a method for culturing tenocytes comprising the step of incubating tenocytes in a culture medium comprising insulin or functional derivative.
Abstract: The invention relates to immunostimulatory nucleic acid compositions and methods of using the compositions. The T-rich nucleic acids contain poly T sequences and/or have greater than 25% T nucleotide residues. The TG nucleic acids have TG dinucleotides. The C-rich nucleic acids have at least one poly-C region and/ore greater than 50% c nucleotides. These immunostimulatory nucleic acids function in a similar manner to nucleic acids containing CpG motifs. The invention also encompasses preferred CpG nucleic acids.
Type:
Application
Filed:
February 26, 2009
Publication date:
July 30, 2009
Applicants:
University of Iowa Research Foundation, Coley Pharmaceutical GmbH
Inventors:
Arthur M. Krieg, Christian Schetter, Jorg Vollmer
Abstract: The present invention concerns groups of compounds derived from tunicates of the Synoicum species, as well as to pharmaceutical compositions comprising these compounds, and uses thereof. Extracts from tunicates show selective toxicity against several different cancer cell lines in the NCI 60 cell line panel. These compounds are useful in the effective treatment of cancers, particularly malignant melanomas, colon cancer, and renal cancer cell lines.
Type:
Application
Filed:
September 18, 2006
Publication date:
July 30, 2009
Applicants:
University of South Florida, UAB Research Foundation
Inventors:
Bill Baker, Thushara Diyabalanage, James B. McClintock, Charles D. Amsler
Abstract: A technique allowing manufacturers to produce woven moisture management fabrics with good moisture transfer properties is based upon a model of the fabric construction, thereby avoiding a manufacturing trial-and-error process. An initial woven fabric design including hydrophilic and hydrophobic yarns are modeled, the warp and weft yarns generally lying in a plane of the fabric. By orthographic projection onto respective planes substantially parallel to the plane of the fabric, a first view and an opposing second view of a unit cell of the model is produced. If the total projected area of hydrophobic yarn on one of the first and second views is between 40% and 70% of the total projected area, and total projected area of hydrophilic yarn on the other of the first and second views exceeds 50% of the total projected area, then a fabric according to the fabric design will have near optimum moisture wicking properties and is manufactured to the design.
Abstract: A process and a kit are provided for detecting differences in two or more samples of protein, including proteins bearing post-translational modifications and peptides. Proteins are prepared, for example, from each of a different group of cell samples or body fluid samples to be compared. Each protein extract is labeled with a different one of a luminescent dye from a matched set of dyes. The matched dyes have generally the same ionic and pH characteristics but emit light at different wavelengths to exhibit a different color upon luminescence detection. The labeled protein extracts are mixed together and separated together by electrophoresis or a chromatographic method. The separation is observed to detect proteins unique to one sample or present in a greater ratio in one sample than in the other. Those unique or excess proteins will fluoresce the color of one of the dyes used. Proteins common to each sample migrate together and fluoresce the same.
Type:
Grant
Filed:
May 1, 2002
Date of Patent:
July 28, 2009
Assignee:
Carnegie Mellon University
Inventors:
Jonathan Minden, Alan Waggoner, Susan Janet Fowler
Abstract: Symmetrical/asymmetrical bidirectional S-shaped I-V characteristics with trigger voltages ranging from 10 V to over 40 V and relatively high holding current are obtained for advanced sub-micron silicided CMOS (Complementary Metal Oxide Semiconductor)/BiCMOS (Bipolar CMOS) technologies by custom implementation of P1-N2-P2-N1//N1-P3-N3-P1 lateral structures with embedded ballast resistance 58, 58A, 56, 56A and periphery guard-ring isolation 88-86. The bidirectional protection devices render a high level of electrostatic discharge (ESD) immunity for advanced CMOS/BiCMOS processes with no latchup problems. Novel design-adapted multifinger 354/interdigitated 336 layout schemes of the ESD protection cells allow for scaling-up the ESD performance of the protection structure and custom integration, while the I-V characteristics 480 are adjustable to the operating conditions of the integrated circuit (IC).
Type:
Grant
Filed:
November 30, 2005
Date of Patent:
July 28, 2009
Assignees:
Intersil Americas Inc., University of Central Florida
Inventors:
Javier A. Salcedo, Juin J. Liou, Joseph C. Bernier, Donald K. Whitney
Abstract: A volume Bragg grating (VBG) has a narrow wavelength. The wavelength is changed by changing an angle of the VBG or a temperature of the VBG. Thus, the present invention has a narrow wavelength, a bright laser, a simple system and an adjustable reflection for a wide application to laser systems.
Abstract: Single-shot methods suitable for determining capillary pressure and relative permeability curves in petroleum reservoir core plugs are proposed. Three classes of measurement are outlined. (i) Measurements undertaken with steady state gas flow and stationary water or oil phases in the rock. SPRITE (Single-Point Ramped Imaging with T1 Enhancement) MRI (Magnetic Resonance Imaging) spin density images map spatially varying fluid content. (ii) Similar measurements are proposed with a stationary gas phase and flowing water or oil phases. (iii) Measurements are also possible with either water or oil as the stationary phase, with the other phase undergoing steady state flow. In all cases the outflow boundary condition is maintained, capillary pressure zero, by washing the outlet face of the sample with the stationary fluid phase.
Abstract: A method and device for the rehabilitation of patients that have suffered loss of motor control of an appendicular joint due to neurological damage. The method includes attempted contraction by a patient of a muscle that serves to move an affected joint coupled with the production of a perception by the patient that the joint is being moved more than it really is. The method results in dramatic non-transient improvements in motor control of the joint. The device provides an apparatus for performance of the method.
Abstract: Codon-optimized nucleic acids encoding influenza polypeptides and uses of the nucleic acids and polypeptides for inducing immune responses are provided herein.
Abstract: The invention generally relates to a method for fractionating plant material into valuable components including beta-glucan. The method uses an organic solvent and water instead of water alone, acidified water and/or aqueous alkali as a solvent for the slurrying of a grain flour. In addition to concentrating beta-glucan, other product fractions produced by the method include starch concentrate, and organic solvent solubles. If enzyme treatments are used, other product fractions include dextrin, protein hydrolysates and organic solvent solubles. The process is particularly effective in concentrating beta-glucans in a state close to its native form from the endosperm of barley and oat grains.
Type:
Grant
Filed:
September 26, 2001
Date of Patent:
July 28, 2009
Assignee:
Governors of the University of Alberta, The
Abstract: The subject invention concerns platinum complexes that exhibit antitumor cell and/or antiparasitic activity. The subject invention also concerns the use of platinum complexes of the invention to treat oncological and inflammatory disorders. The platinum complexes of the invention can also be used to treat or prevent infection by a virus or a bacterial or parasitic organism in vivo or in vitro.
Type:
Grant
Filed:
August 13, 2004
Date of Patent:
July 28, 2009
Assignee:
University of South Florida
Inventors:
Heidi Kay, Jay W. Palmer, Joseph A. Stanko
Abstract: The present invention provides substantially purified peptide portions of a promyostatin polypeptide. For example, the invention provides proteolytic fragments of a promyostatin polypeptide such as a myostatin prodomain or a mature myostatin peptide, as well as functional peptide portions a myostatin prodomain an myostatin. Also provided is a mutant promyostatin polypeptide, which is resistant to proteolytic cleavage, for example, cleavage into a myostatin prodomain and a mature myostatin peptide. The present invention also provides a polynucleotide encoding a peptide portion of a promyostatin polypeptide. In addition, antibodies that specifically bind a peptide portion of a promyostatin polypeptide are provided. The invention further provides methods of identifying a functional peptide portion of a promyostatin polypeptide.
Type:
Grant
Filed:
July 27, 2000
Date of Patent:
July 28, 2009
Assignee:
The Johns Hopkins University School of Medicine
Abstract: An efficient power driver for color light emitting diodes (LED) is disclosed for driving multiple LEDs for producing different desired colors. Such LED combinations comprising LEDs with different primary colors are suitable for implementing pixels in displaying a digitized image. This disclosed invention provides switching power conversion embodiments such that a single apparatus drives different color LEDs. Furthermore, the disclosed invention provides configurations with and without input to output isolation while enabling control of the current through each LED, for instance by an inductor or operating condition.
Type:
Grant
Filed:
October 24, 2006
Date of Patent:
July 28, 2009
Assignee:
The University of Hong Kong
Inventors:
Man Hay Pong, Franki Ngai Kit Poon, Joe Chui Pong Liu
Abstract: The present invention relates to therapeutic protocols and pharmaceutical compositions designed to treat and prevent cancer. More specifically, the present invention relates to a novel method of treating cancer using antagonists to the endothelin B receptor (ETB) or inactive mimic forms of endothelin-1. The pharmaceutical compositions of the invention are capable of selectively inhibiting the early events associated with the development of cancer. The present invention further relates to screening assays to identify compounds which inhibit ETB activation.